Skip to main content
Content Starts Here GSA Federal Advisory Committee Act (FACA) Database Skip to main content

Committee Detail

Note: An Annual Comprehensive Review, as required by §7 of the Federal Advisory Committee Act, is conducted each year on committee data entered for the previous fiscal year (referred to as the reporting year). The data for the reporting year is not considered verified until this review is complete and the data is moved to history for an agency/department. See the Data From Previous Years section at the bottom of this page for the committee’s historical, verified data.

Details on agency responses to committee recommendations can be found under the Performance Measures section for each committee in the fields “Agency Feedback” and “Agency Feedback Comment.”


HHS - 21482 - National Science Advisory Board for Biosecurity - Authorized by Law
Hide Section - GENERAL INFORMATION

GENERAL INFORMATION

Committee NameNational Science Advisory Board for BiosecurityAgency NameDepartment of Health and Human Services
Fiscal Year2022Committee Number21482
Original Establishment Date11/22/1962Committee StatusChartered
Actual Termination Date Committee URLhttps://osp.od.nih.gov/biotechnology/national-s...
New Committee This FYNoPresidential Appointments*No
Terminated This FYNoMax Number of Members*25
Current Charter Date4/7/2022Designated Fed Officer Position Title*Acting Director, Division of Biosafety, Biosecurity, and Emerging Biotechnology Policy
Date Of Renewal Charter4/7/2024Designated Federal Officer Prefix
Projected Termination Date Designated Federal Officer First Name*Cari
Exempt From Renewal*NoDesignated Federal Officer Middle Name
Specific Termination AuthorityDesignated Federal Officer Last Name*Young
Establishment Authority*Authorized by LawDesignated Federal Officer SuffixSc.M.
Specific Establishment Authority*42 USC 217a, Section 222 of the PHS, PAHPA PL 109-417, Section 205, 120 Stat. 2851Designated Federal Officer Phone*(301) 594-3746
Effective Date Of Authority*11/22/1962Designated Federal Officer Fax*(301) 496-9839
Exempt From EO 13875 Discretionary CmteNot ApplicableDesignated Federal Officer Email*youngce@mail.nih.gov
Committee Type*Continuing
Presidential*No
Committee Function*Scientific Technical Program Advisory Board
Hide Section - RECOMMENDATION/JUSTIFICATIONS

RECOMMENDATION/JUSTIFICATIONS

Agency Recommendation*Continue
Legislation to Terminate RequiredNot Applicable
Legislation StatusNot Applicable
How does cmte accomplish its purpose?*The purpose of the National Science Advisory Board for Biosecurity (NSABB) is to provide, as requested, advice, guidance, and recommendations regarding biosecurity oversight of dual use research, defined as biological research with legitimate scientific purpose that may be misused to pose a biologic threat to public health and/or national security. The NSABB will provide advice on and recommend specific strategies for the efficient and effective oversight of federally conducted or supported dual use biological research, taking into consideration both national security concerns and the needs of the research community to foster continued rapid progress in public health and agricultural research. Toward this end, the NSABB will also provide strategies to raise awareness of dual use issues relevant to the life science and related interdisciplinary research communities. In addition, pursuant to Section 205 of the Pandemic and All-Hazards and Preparedness Act (PAHPA), when requested by the Secretary of Health and Human Services (HHS), the NSABB shall also provide to relevant Federal departments and agencies, advice, guidance, or recommendations concerning (1) a core curriculum and training requirements for workers in maximum containment and biological laboratories; and (2) periodic evaluation of maximum containment biological laboratory capacity nationwide and assessments of the future need for increased laboratory capacity. HHS convened the NSABB in February 2022 and working with USG partners, the Board was charged to evaluate and provide recommendations on the scope and effectiveness of U.S. biosecurity policy frameworks governing research involving enhanced potential pandemic pathogens and dual use research of concern.
How is membership balanced?*In advising on the efficient and effective oversight of dual use life sciences research, the NSABB must consider both public health and national security needs and the needs of the research community. Because this requires a diverse range of expertise, the NSABB will consist of not more than 25 voting members who provide broad expertise in areas such as molecular biology/genomics, microbiology (bacteriology), microbiology (virology), clinical Infectious diseases/diagnostics, institutional and/or laboratory, biosafety and biosecurity, public health/epidemiology, health physicist/radiation safety, pharmaceutical production, veterinary medicine, plant health, food production, bioethics, national security, military biodefense programs and military medicine, intelligence, biodefense, law and law enforcement, academia, scientific publishing, export controls, industry perspective and public perspective. In appointing these members, careful consideration is also given to geographic, gender, and race/ethnicity balance. In addition, nonvoting ex officio members represent HHS.
How frequent & relevant are cmte mtgs?*Meetings of the NSABB will be held approximately three times within a fiscal year and may be convened on an as-needed basis. Due to COVID-19 Pandemic restrictions, NSABB held two virtual meetings on 2/28/2022 and 9/21/2022.
Why advice can't be obtained elsewhere?*The NSABB is the only Federal advisory committee chartered to advise the Federal Government on the management and oversight of dual use research; a constantly evolving challenge with significant implications for national biodefense, biosafety and biosecurity, and maintenance of a strong U.S. bioeconomy. The NSABB brings together a unique and broad range of perspectives and expertise, including biomedical, plant, and animal research; biosecurity, law, law enforcement, scientific publishing, biodefense, and intelligence.
Why close or partially close meetings?N/A
Recommendation RemarksMembership: Dr. Tahmassian resigned 8/17/2022; Dr. Sandri-Goldin's term ended 6/14/2022. Dr. Louissaint was inadvertently left off of the FY2021 member listing; her term dates are 02/27/2021 - 10/12/2022.

Administrative Extensions: The following members have been administratively extended: Drs. Bernard, Denison, Fletcher, Grabenstein, Parker, and Silver.

Ex Officio: Dr. Kuhnert-Tallman's end term date was incorrectly reported in FY2021; end date is 9/30/2024. Dr. Fauci's term end date was reported in FY2021 as 6/14/2023; due to his retirement the end term date has been changed to 12/31/2022.

The Designated Federal Officer and Committee Decision Maker was changed from Dr. Jessica Tucker to Ms. Cari Young. These positions are held by the same individual based on assigned duties within the IC.

Per the Charter, NSABB will consist of not more than 25 voting members and there may be nonvoting ex officio members from HHS. At this time, there are 14 voting members and 4 ex officio members. The number of Ex Officios could change as the Charter doesn't specify a maximum number for ex officio members.
Hide Section - PERFORMANCE MEASURES

PERFORMANCE MEASURES

Outcome Improvement To Health Or Safety*YesAction Reorganize Priorities*Yes
Outcome Trust In GovernmentYesAction Reallocate ResourcesNo
Outcome Major Policy ChangesYesAction Issued New RegulationsNo
Outcome Advance In Scientific ResearchNoAction Proposed LegislationNo
Outcome Effective Grant MakingNoAction Approved Grants Or Other PaymentsNo
Outcome Improved Service DeliveryNoAction OtherYes
Outcome Increased Customer SatisfactionNoAction CommentThe NSABB will advise the Secretary, HHS, and the Director of the National Institutes of Health (NIH). In addition, when requested by the Secretary, HHS, the NSABB will advise the heads of all Federal entities that conduct, support, or have an interest in life sciences research on the matters delineated in Section 205 of the Pandemic and All-Hazards and Preparedness Act.
Outcome Implement Laws/Reg RequirementsNoGrants Review*No
Outcome OtherYesNumber Of Grants Reviewed0
Outcome CommentThe Committee is advisory on significant policy issues that have the potential to affect the oversight of all federally-funded life sciences research. In addition, the policies that are informed by its recommendations help ensure that the scientific community conducts and communicates its research in a responsible manner.Number Of Grants Recommended0
Cost Savings*Unable to DetermineDollar Value Of Grants Recommended$0.00
Cost Savings CommentThis Committee provides advice, guidance, and leadership as stated in the narrative above. It can take many years for the impacts of these recommendations to come to fruition.Grants Review CommentN/A
Number Of Recommendations*229Access Contact Designated Fed. Officer*Yes
Number Of Recommendations CommentThe committee issued no recommendations in FY2022.Access Agency WebsiteYes
% of Recs Fully Implemented*0.00%Access Committee WebsiteYes
% of Recs Fully Implemented CommentDue to the large breadth and complexity of the recommendations made by this committee on policy and program areas, NIH staff is unable to determine which recommendations have been fully or partially implemented solely in response to this committee’s activities.Access GSA FACA WebsiteYes
% of Recs Partially Implemented*0.00%Access PublicationsNo
% of Recs Partially Implemented CommentDue to the large breadth and complexity of the recommendations made by this committee on policy and program areas, NIH staff is unable to determine which recommendations have been fully or partially implemented solely in response to this committee’s activities.Access OtherNo
Agency Feedback*YesAccess CommentN/A
Agency Feedback Comment*Information is provided to the public at each meeting. The public can view information related to the Committee through the committee’s official website.Narrative Description*The purpose of the National Science Advisory Board for Biosecurity (NSABB) is to provide advice, guidance, and leadership regarding biosecurity oversight of dual use research, defined as biological research with legitimate scientific purpose that may be misused to pose a threat to public health and/or national security. The NSABB will advise the Secretary, HHS, and the Director of the National Institutes of Health (NIH). In addition, when requested by the Secretary, HHS, the NSABB will advise the heads of all Federal entities that conduct, support, or have an interest in life sciences research on the matters delineated in Section 205 of the Pandemic and All-Hazards and Preparedness Act. The NSABB advises on and recommends specific strategies for the efficient and effective oversight of federally conducted or supported dual use biological research, taking into consideration both national security concerns and the needs of the research community.
Hide Section - COSTS

COSTS

Payments to Non-Federal Members*$8,200.00Est Payments to Non-Fed Members Next FY*$15,000.00
Payments to Federal Members*$5,407.00Est. Payments to Fed Members Next FY*$40,560.00
Payments to Federal Staff*$143,120.00Estimated Payments to Federal Staff*$100,236.00
Payments to Consultants*$0.00Est. Payments to Consultants Next FY*$0.00
Travel Reimb. For Non-Federal Members*$0.00Est Travel Reimb Non-Fed Members nextFY*$33,113.00
Travel Reimb. For Federal Members*$0.00Est Travel Reimb For Fed Members*$0.00
Travel Reimb. For Federal Staff*$0.00Est. Travel Reimb to Fed Staff Next FY*$0.00
Travel Reimb. For Consultants*$0.00Est Travel Reimb to Consultants Next FY*$0.00
Other Costs$181,579.00Est. Other Costs Next FY*$188,103.00
Total Costs$338,306.00Est. Total Next FY*$377,012.00
Date Cost Last Modified11/7/2022 3:45 PMEst. Fed Staff Support Next FY*0.60
Federal Staff Support (FTE)*0.80Est Cost RemarksThe estimated federal staff costs has decreased due to the percentage reduction of the projected level of federal staff support, reported by the Designated Federal Officer. Projected costs for administrative overhead for FY23 were increased in the event that in-person/hybrid meetings resume.
Cost RemarksDaily salary costs have been estimated for Federal and/or Ex Officio members of this committee. The dollar figure represents a portion of their annual salary. No funds have been transferred between the committee and the agency. No additional funds are paid to Federal employees due to membership on this committee. Four Federal and/ or Ex officio members are identified in the member section and the same four ex officio and/or Federal members attended meetings during the fiscal year.  
Hide Section - Interest Areas

Interest Areas

Category
Area
Health
Safety
Medicine
Health and Health Research
National Defense
National Security and Defense
Hide Section - MEMBERS,MEETINGS AND ADVISORY REPORTS

MEMBERS,MEETINGS AND ADVISORY REPORTS

To View all the members, meetings and advisory reports for this committee please click here
Hide Section - CHARTERS AND RELATED DOCS

CHARTERS AND RELATED DOCS

No Documents Found
Hide Section - DATA FROM PREVIOUS YEARS

DATA FROM PREVIOUS YEARS

Committee

Data from Previous Years

 
ActionCommittee System IDCommittee NameFiscal Year
 COM-040327National Science Advisory Board for Biosecurity2021
 COM-038606National Science Advisory Board for Biosecurity2020
 COM-036479National Science Advisory Board for Biosecurity2019
 COM-034678National Science Advisory Board for Biosecurity2018
 COM-001708National Science Advisory Board for Biosecurity2017
 COM-002297National Science Advisory Board for Biosecurity2016
 COM-004091National Science Advisory Board for Biosecurity2015
 COM-004416National Science Advisory Board for Biosecurity2014
 COM-006234National Science Advisory Board for Biosecurity2013
 COM-006882National Science Advisory Board for Biosecurity2012
 COM-008283National Science Advisory Board for Biosecurity2011
 COM-009061National Science Advisory Board for Biosecurity2010
 COM-010086National Science Advisory Board for Biosecurity2009
 COM-010953National Science Advisory Board for Biosecurity2008
 COM-012229National Science Advisory Board for Biosecurity2007
 COM-012532National Science Advisory Board for Biosecurity2006
 COM-014064National Science Advisory Board for Biosecurity2005
 COM-014595National Science Advisory Board for Biosecurity2004